---
document_datetime: 2025-03-05 16:26:25
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/quofenix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: quofenix-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.787012
conversion_datetime: 2025-12-29 23:10:51.139968
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Quofenix

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0030              | C.I.3.z - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Other variation | 25/02/2025                          |                                             | SmPC and PL                      |           |
| IB/0029/G            | This was an application for a group of variations.                                                                                                                                             | 31/01/2025                          | n/a                                         |                                  |           |

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                           |            |            |                       |                                                                                                                                                                                                                                 |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10822 /202406 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                                                                                                                                                                                                                                                                                                                                                    | 16/01/2025 | n/a        |                       | PRAC Recommendation - maintenance                                                                                                                                                                                               |
| IAIN/0028/G         | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 14/10/2024 |            | Annex II and PL       |                                                                                                                                                                                                                                 |
| R/0026              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 27/06/2024 | 22/08/2024 | SmPC, Annex II and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Quofenix remains favourable in the approved indications and therefore recommends the renewal of the marketing |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                                                                                      |            |            |      | authorisation with unlimited validity.   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|------------------------------------------|
| IB/0025/G           | This was an application for a group of variations. B.I.d.1.c - Stability of AS - Change in the re-test period/storage period or storage conditions - Change to an approved stability protocol B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data | 11/03/2024 | n/a        |      |                                          |
| IB/0024/G           | This was an application for a group of variations. B.II.f.1.e - Stability of FP - Change to an approved stability protocol B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                 | 29/02/2024 | 22/08/2024 | SmPC |                                          |
| PSUSA/10822 /202306 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                                                                                                                                                                                                                           | 11/01/2024 | n/a        |      | PRAC Recommendation - maintenance        |
| IB/0023             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                            | 08/12/2023 | 22/08/2024 | SmPC |                                          |
| IA/0021             | B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                                                                | 24/03/2023 | n/a        |      |                                          |

<div style=\"page-break-after: always\"></div>

| IB/0020             | B.II.c.1.z - Change in the specification parameters and/or limits of an excipient - Other variation                                                                    | 10/02/2023   | n/a        |             |                                                                                                                                                                    |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10822 /202206 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                             | 12/01/2023   | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                  |
| IB/0019             | B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                              | 13/10/2022   | 03/02/2023 | SmPC and PL |                                                                                                                                                                    |
| PSUSA/10822 /202112 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                             | 07/07/2022   | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                  |
| IB/0017             | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data | 27/06/2022   | n/a        |             |                                                                                                                                                                    |
| IA/0016             | B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure                                                                   | 16/05/2022   | n/a        |             |                                                                                                                                                                    |
| IB/0014             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                         | 25/02/2022   | 03/02/2023 | SmPC        | To update sections 5.3 and 6.6 of the SmPC to implement wording on the identified environmental risk following the assessment of an environmental risk assessment. |
| PSUSA/10822 /202106 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                             | 13/01/2022   | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                  |
| PSUSA/10822 /202012 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                             | 08/07/2021   | n/a        |             | PRAC Recommendation - maintenance                                                                                                                                  |

<div style=\"page-break-after: always\"></div>

| IB/0011   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 05/07/2021   | n/a        |             |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|
| IB/0012   | B.I.d.1.a.4 - Stability of AS - Change in the re-test period/storage period - Extension or introduction of a re-test period/storage period supported by real time data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 15/06/2021   | n/a        |             |
| II/0003   | C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 25/02/2021   | 26/03/2021 | SmPC and PL |
| II/0007/G | This was an application for a group of variations. B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.5.z - Change to in-process tests or limits applied during the manufacture of the finished product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the | 18/03/2021   | n/a        |             |

<div style=\"page-break-after: always\"></div>

| B.II.e.2.c - Change in and/or limits of the immediate finished product - Deletion specification parameter parameter) B.II.b.5.b - Change to applied during the manufacture product - Addition of a B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the finished or intermediate   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.4.d - Change in the batch size (including batch size ranges) of the finished product - The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes A.7 - Administrative change - Deletion of manufacturing sites B.II.b.1.c - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch release/control, and secondary packaging, for biol/immunol medicinal products or pharmaceutical forms manufactured by complex manufacturing   |            |     |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| II/0009             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 11/02/2021 | n/a |                                   |
| PSUSA/10822 /202006 | Periodic Safety Update EU Single assessment - delafloxacin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 14/01/2021 | n/a | PRAC Recommendation - maintenance |

<div style=\"page-break-after: always\"></div>

| IAIN/0008   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 26/11/2020   | 26/03/2021   | SmPC and PL                      |              |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|----------------------------------|--------------|
| IA/0005/G   | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test procedure is already authorised B.I.b.2.b - Change in test procedure for AS or starting material/reagent/intermediate - Deletion of a test procedure for the AS or a starting material/reagent/intermediate, if an alternative test | 26/08/2020   | n/a          |                                  |              |
| IB/0004     | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 28/05/2020   | n/a          |                                  |              |
| IB/0002/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking - Changes in imprints, bossing or other markings Replacement or addition of a                                                                                                                                                                                                                                                                                      | 20/03/2020   | 26/03/2021   | SmPC, Annex II, Labelling and PL | B.II.b.1.a - |

<div style=\"page-break-after: always\"></div>

<!-- image -->

| manufacturing site for the site B.II.b.1.b - Replacement manufacturing site for the site B.II.b.1.e - Replacement manufacturing site for the manufacturing operation(s) release, batch control, packaging, for non-sterile B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process   |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

<!-- image -->

| the finished or intermediate in the manufacturing process B.II.b.3.a - Change in the the finished or intermediate in the manufacturing process B.II.b.4.a - Change in the size ranges) of the finished compared to the originally B.II.b.5.z - Change to in-process applied during the manufacture product - Other variation B.II.d.2.a - Change in test product - Minor changes procedure B.II.d.2.a - Change in test product - Minor changes procedure B.II.d.2.a - Change in test product - Minor changes procedure B.II.d.2.a - Change in test product - Minor changes procedure B.II.e.2.b - Change in the and/or limits of the immediate finished product - Addition parameter to the specification test method B.II.e.2.b - Change in the and/or limits of the immediate finished product - Addition   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|           | test method B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation B.II.e.4.a - Change in shape or dimensions of the container or closure (immediate packaging) - Non-   |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IAIN/0001 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 26/02/2020 | n/a |